8.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Viatris Inc Aktie (VTRS) Neueste Nachrichten
VTRS Investors Have Opportunity to Join Viatris Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Viatris Certified as a Great Place to Work in India for the Fourth Consecutive Year - CXOToday.com
VTRS ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Viatris Inc. Investment - ACCESS Newswire
Viatris Enters Oversold Territory - Nasdaq
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible - GlobeNewswire
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman - TradingView
How Is Viatris’ Stock Performance Compared to Other Biotech Stocks? - TradingView
How Is Viatris’ Stock Performance Compared To Other Biotech Stocks? - Barchart.com
Viatris Inc. Investor News: If You Have Suffered Losses in - GlobeNewswire
Viatris Inc. Investor News: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc.VTRS - PR Newswire
VTRS ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Viatris Inc. (VTRS) for Potential Securities Law Violations - The Globe and Mail
Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears - MSN
Lost Money on Viatris Inc.(VTRS)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire
VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire
Viatris Inc. (VTRS) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire
Viatris to Report First Quarter 2025 Financial Results on May 8, 2025 - The Malaysian Reserve
Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are - Bluefield Daily Telegraph
Viatris Inc. Announcement: If You Have Suffered Losses in - GlobeNewswire
The Global Market for Paclitaxel Injections Presents an - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris – VTRS - GlobeNewswire
The Human Factor: Device Stress Tests Run Gamut to Mimic Real-World Use - Viatris
Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch
Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey
Viatris Inc. Being Investigated on Behalf of Viatris Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
VTRS Stock Quote - richtv.io
Viatris Inc. stock falls Friday, underperforms market - MarketWatch
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of - EIN News
Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - ACCESS Newswire
Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateVTRS - ACCESS Newswire
VTRS Investigation: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire
Viatris Inc. Announces Quarterly Dividend, Payable on March 18, 2025 -February 27, 2025 at 06:30 am EST - Marketscreener.com
Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now? - MSN
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider.com
Opus, Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug - Bloomberg Law
Viatris Inc. Under Investor Scrutiny: Levi & Korsinsky Launches Securities Investigation - Apna Kal
Viatris Stock Plummets Over 15% Amid Earnings Miss and FDA Warning – Investors Encouraged to Take Action - Apna Kal
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):